Skip to main navigation

Sorrento Therapeutics

Search

Client Header Links

  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • Covid-19
    • Immuno-Oncology
    • Pain
    • Lymphatic Delivery System
    • Product Candidates
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC FILINGS
    • Stock
    • Analyst Coverage
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Career
  • Contact

News Releases

News Releases

Jan 26, 2021
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
Jan 19, 2021
Sorrento to Present Data Demonstrating STI-2020 Preserves Binding Against UK B.1.1.7 SARS-CoV-2 Mutated Spike Protein
Jan 19, 2021
Dr. Henry Ji to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 20, 2021
Jan 10, 2021
Dr. Henry Ji to Participate in the H.C. Wainwright Bioconnect 2021 Virtual Investor Conference

Tools

  • Print

    Print

  • Email Alerts

    Email Alerts

  • RSS Feeds

    RSS Feeds

  • Email Page

    Email Page

© 2021 Sorrento Therapeutics. All Rights Reserved.

Footer

    Terms of Use Privacy Policy DMCA Trademarks Linking Policy
logo

Client Header Links

  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • Covid-19
    • Immuno-Oncology
    • Pain
    • Lymphatic Delivery System
    • Product Candidates
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC FILINGS
    • Stock
    • Analyst Coverage
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Career
  • Contact